Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial is a research paper published in JAMA Network Open (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
NIAID NIH HHS
Grant: UM1 AI069412
NHLBI NIH HHS
Grant: R01 HL149683
NIAID NIH HHS
Grant: UM1 AI148684
NIAID NIH HHS
Grant: R01 AI029168
NIAID NIH HHS
Grant: UM1 AI148575
National Institutes of Health
Grant: 5R01AI029168-22
Statistical Issues in AIDS Research
FWCI
0.39
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals